换一批
换一批Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
第一作者：
Robert J,Morgan
第一单位：
Division of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California 91010, USA. rmorgan@coh.org
作者：
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);女(雌)性(Female);胃肠肿瘤(Gastrointestinal Neoplasms);人类(Humans);输注, 胃肠外(Infusions, Parenteral);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);腹膜肿瘤(Peritoneal Neoplasms);胃肿瘤(Stomach Neoplasms);紫杉烷类(Taxoids);治疗结果(Treatment Outcome)
PMID
14676112
发布时间
2018-11-30
- 浏览113
Clinical cancer research
5896-901页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
